Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 428
Selected: 0
NCT IDTitle
NCT04373967Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
NCT02930317Evaluate Efficacy and Safety of Recombinant Factor VIII (rFVIII)Treatment of Severe or Moderately Severe Hemophilia A
NCT06150014A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
NCT06230588A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
NCT06662773Drug-Drug Interaction (DDI) Study for TQB3616
NCT07338838To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
NCT06218771A Study of TQB3454 Tablets in Patients With Blood Tumors
NCT07047365TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT03735264Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer(ALTER-L034)
NCT05834543Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
NCT06408285A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects
NCT04073550Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer
NCT04180150A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B
NCT04408079A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets
NCT05735496Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT03706287Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC
NCT03800706A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma
NCT07327281A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects
NCT05346952A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC).
NCT05646758A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
NCT03777085Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)
NCT04804904A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects
NCT04941404A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)
NCT04325776A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis
NCT06429397Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
NCT07172126Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
NCT05718167TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer.
NCT04623892A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tumors
NCT05130515Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.
NCT05645315Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors
NCT06143735A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
NCT06089278A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
NCT04216082A Study of Anlotinib in Subjects With Advanced Malignancy
NCT05987358A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
NCT06507891A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
NCT05051930A Clinical Trial of TQC3721 Suspension for Inhalation
NCT05765357Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers
NCT05493995A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
NCT02388919Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303)
NCT04923607Phase I Clinical Trial of TQC2731 Injection
NCT05380934A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects
NCT05800106A Bioequivalence Study of Sunitinib Malate Capsules.
NCT02752516A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics
NCT05068206A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx
NCT05783921A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma
NCT05496569TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
NCT05426798Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
NCT04854681Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers
NCT07267130A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects
NCT06943677A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors